RT Journal Article
SR Electronic
A1 Summers, Jaye
T1 Disease Activity in Year 1 Predicts Long-term Outcomes in Patients Taking Fingolimod
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 9
SP 17
OP 17
DO 10.1177/1559897715589077
UL http://mdc.sagepub.com/content/15/9/17.2.abstract
AB In patients with relapsing multiple sclerosis who participated in the TRANSFORMS trial, magnetic resonance imaging activity and relapses in the first year predicted clinical outcomes over 3 years of the extension trial. Switching from interferon beta-1a to fingolimod at 12 months reduced the proportion of patients with focal magnetic resonance imaging activity and relapse by 70%.